Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Health Science Center, Houston
With
GlaxoSmithKline
Age
0–98
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients from 9 months of age up to 98 years of age.
Clinical diagnosis of impetigo, folliculitis, or minor soft tissue infection including secondarily infected eczema presumed to be caused by Staphylococcus aureus.
The patient, and if applicable the parent or guardian, is able to give informed consent
Females of child bearing potential have a negative urine pregnancy test.
Patient, and if applicable parent or guardian, are willing to and capable of complying with the study protocol.
You may not be if
Subject who has used a topical antibacterial medication to the area being treated within the last 48 hours.
Subject who has been enrolled in a clinical trial within the last 30 days.
Subject with signs of systemic infection (such as fever), or with evidence of abscess or cellulitis at the site to be treated.
Subject has a bacterial skin infection which would not be appropriately treated by a topical antibiotic in the opinion of the investigator
Subjects who have taken oral antibiotics within the last 7 days.
Subjects with known sensitivity to the study medication.
The subject is pregnant or breastfeeding
Clareo Health | Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
